TY - JOUR AU - Cairncross, G. AU - Wang, M. AU - Shaw, E. PY - 2013 DA - 2013// TI - Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402 JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.43.2674 DO - 10.1200/JCO.2012.43.2674 ID - Cairncross2013 ER - TY - JOUR AU - Bent, M. J. AU - Brandes, A. A. AU - Taphoorn, M. J. PY - 2013 DA - 2013// TI - Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951 JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.43.2229 DO - 10.1200/JCO.2012.43.2229 ID - Bent2013 ER - TY - JOUR AU - Yan, H. AU - Parsons, D. W. AU - Jin, G. PY - 2009 DA - 2009// TI - IDH1 and IDH2 mutations in gliomas JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0808710 DO - 10.1056/NEJMoa0808710 ID - Yan2009 ER - TY - JOUR AU - Cairncross, J. G. AU - Wang, M. AU - Jenkins, R. B. PY - 2014 DA - 2014// TI - Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.49.3726 DO - 10.1200/JCO.2013.49.3726 ID - Cairncross2014 ER - TY - JOUR AU - Olar, A. AU - Wani, K. M. AU - Alfaro-Munoz, K. D. PY - 2015 DA - 2015// TI - IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas JO - Acta Neuropathol VL - 129 UR - https://doi.org/10.1007/s00401-015-1398-z DO - 10.1007/s00401-015-1398-z ID - Olar2015 ER - TY - JOUR AU - Eckel-Passow, J. E. AU - Lachance, D. H. AU - Molinaro, A. M. PY - 2015 DA - 2015// TI - Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1407279 DO - 10.1056/NEJMoa1407279 ID - Eckel-Passow2015 ER - TY - JOUR AU - Hathout, L. AU - Pope, W. B. AU - Lai, A. PY - 2015 DA - 2015// TI - Radial expansion rates and tumor growth kinetics predict malignant transformation in contrast-enhancing low-grade diffuse astrocytoma JO - CNS Oncol VL - 4 UR - https://doi.org/10.2217/cns.15.16 DO - 10.2217/cns.15.16 ID - Hathout2015 ER - TY - JOUR AU - Taphoorn, M. J. AU - Schiphorst, A. K. AU - Snoek, F. J. PY - 1994 DA - 1994// TI - Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy JO - Ann Neurol VL - 36 UR - https://doi.org/10.1002/ana.410360111 DO - 10.1002/ana.410360111 ID - Taphoorn1994 ER - TY - JOUR AU - Klein, M. AU - Heimans, J. J. AU - Aaronson, N. K. PY - 2002 DA - 2002// TI - Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)11398-5 DO - 10.1016/S0140-6736(02)11398-5 ID - Klein2002 ER - TY - JOUR AU - Vigliani, M. C. AU - Sichez, N. AU - Poisson, M. AU - Delattre, J. Y. PY - 1996 DA - 1996// TI - A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results JO - Int J Radiat Oncol Biol Phys VL - 35 UR - https://doi.org/10.1016/S0360-3016(96)80015-0 DO - 10.1016/S0360-3016(96)80015-0 ID - Vigliani1996 ER - TY - STD TI - Van Den Bent MJ, Erridge S, Vogelbaum M et al. Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion: An Intergroup trial. J Clin Oncol 34, 2016 (suppl; abstr LBA2000) ID - ref11 ER - TY - JOUR AU - Vander Borght, T. AU - Asenbaum, S. AU - Bartenstein, P. PY - 2006 DA - 2006// TI - EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues JO - Eur J Nucl Med Mol Imaging VL - 33 UR - https://doi.org/10.1007/s00259-006-0206-3 DO - 10.1007/s00259-006-0206-3 ID - Vander Borght2006 ER - TY - JOUR AU - Douw, L. AU - Klein, M. AU - Fagel, S. S. PY - 2009 DA - 2009// TI - Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up JO - Lancet Neurol VL - 8 UR - https://doi.org/10.1016/S1474-4422(09)70204-2 DO - 10.1016/S1474-4422(09)70204-2 ID - Douw2009 ER - TY - JOUR AU - Karunamuni, R. AU - Bartsch, H. AU - White, N. S. PY - 2016 DA - 2016// TI - Dose-dependent cortical thinning after partial brain irradiation in high-grade glioma JO - Int J Radiat Oncol Biol Phys VL - 94 UR - https://doi.org/10.1016/j.ijrobp.2015.10.026 DO - 10.1016/j.ijrobp.2015.10.026 ID - Karunamuni2016 ER - TY - JOUR AU - Corn, B. W. AU - Yousem, D. M. AU - Scott, C. B. PY - 1994 DA - 1994// TI - White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83–02) JO - Cancer VL - 74 UR - https://doi.org/3.0.CO;2-K DO - 3.0.CO;2-K ID - Corn1994 ER - TY - JOUR AU - McAleer, M. F. AU - Brown, P. D. PY - 2015 DA - 2015// TI - Neurocognitive function following therapy for low-grade gliomas JO - Semin Radiat Oncol VL - 25 UR - https://doi.org/10.1016/j.semradonc.2015.02.005 DO - 10.1016/j.semradonc.2015.02.005 ID - McAleer2015 ER - TY - JOUR AU - Aaronson, N. K. AU - Taphoorn, M. J. AU - Heimans, J. J. PY - 2011 DA - 2011// TI - Compromised health-related quality of life in patients with low-grade glioma JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.35.5750 DO - 10.1200/JCO.2011.35.5750 ID - Aaronson2011 ER - TY - JOUR AU - Shaw, E. AU - Arusell, R. AU - Scheithauer, B. PY - 2002 DA - 2002// TI - Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/ Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.09.126 DO - 10.1200/JCO.2002.09.126 ID - Shaw2002 ER - TY - JOUR AU - Karim, A. B. AU - Maat, B. AU - Hatlevoll, R. PY - 1996 DA - 1996// TI - A randomized trial on dose–response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844 JO - Int J Radiat Oncol Biol Phys VL - 36 UR - https://doi.org/10.1016/S0360-3016(96)00352-5 DO - 10.1016/S0360-3016(96)00352-5 ID - Karim1996 ER - TY - JOUR AU - Götz, I. AU - Grosu, A. L. PY - 2013 DA - 2013// TI - 18F FET-PET imaging for treatment and response monitoring of radiation therapy in malignant glioma patients - a review JO - Front Oncol VL - 3 UR - https://doi.org/10.3389/fonc.2013.00104 DO - 10.3389/fonc.2013.00104 ID - Götz2013 ER - TY - JOUR AU - Grosu, A. L. AU - Weber, W. A. PY - 2010 DA - 2010// TI - PET for radiation treatment planning of brain tumours JO - Radiother Oncol VL - 96 UR - https://doi.org/10.1016/j.radonc.2010.08.001 DO - 10.1016/j.radonc.2010.08.001 ID - Grosu2010 ER -